Analyzing wastewater has the potential to alert authorities about thousands of health threats at once, from antimicrobial resistance to cholera, according to new research from several European universities.
Ultragenyx to spin off company to develop ‘high risk, high return’ gene therapy for Alzheimer’s disease
Ultragenyx plans to spin off a company dedicated to developing a novel gene therapy for Alzheimer’s disease that makes use of a lysosomal enzyme, the